CLINICAL ROLE -
Expert Discusses Disruptors, High-Cost Drugs in Marketplace
Christina Barrington, PharmD, vice president of pharmacy programs at Priority Health, discusses current disruptors in the marketplace and high-cost drugs.
Expert: “We Should Not Have Waited Until the Pandemic” to Expand Home Infusion
Saira A. Jan, MS, PharmD, discussed a novel pilot program in New Jersey aiming to expand home infusion services in oncology.
Expert: COVID-19 Pandemic Enabled Home Infusion to ‘Skyrocket’
Timothy O’Shea, MS, PharmD, discussed the growth of home infusion programs and how they benefit patients.
Future Goals of Biosimilar Development Could Support Research Gap, Aiding Pharmacists Interchangeability
Kimberly Maxfield, PhD, discussed pharmacist’s role to aid patients when switching to a biosimilar
Pharmacists’ Involvement with Gene Therapies, Potential Candidates, Forecasting Effectively
In this field, Marshall notes that pharmacists can help by building forecasts and assist with managing members’ care before and after gene therapy.
More Biosimilars Are Entering the Pharmacy Side of The Market
Biosimilars in the pharmacy benefit are as effective as their reference drug, but it’s important for the pharmacist to clarify this to patients.
Expert: Improving Efficiency of Biosimilar Operations, Advancing Interchangeable Biosimilar Development Among Top Priorities for FDA
The biosimilar landscape is growing, but the FDA should leverage analytical data to efficiently determine the quality of these products and propel them toward approval, according to a session at the Academy of Managed Care Pharmacy’s Nexus 2023 conference.
Experts Highlight Need for Increased Screening for Dementia, Alzheimer Disease
Approximately 96% physicians feel it is important to assess patients aged 60 years and older for cognitive impairment, but 48% of these patients have no had assessments from their physician.
Interchangeability Designation Still Widely Debated, Prescribers Hesitant About Biosimilars
The FDA is the only authority that can designate a biosimilar as interchangeable with its reference product, which requires that the product has similar clinical results for the same indication.
Pharmacists Play Important Role in Behavioral Health Care, Preventing Over- or Under-Prescribing
There are 3 main medication-related issues for mental health care, which includes polypharmacy, nonadherence to prescribed medication, and underutilization of medications.
Key Market Trends for the Current Specialty Drug Pipeline
Areas of focus for specialty medications include biosimilars, cancer treatments, and drugs across disease states such as inflammatory conditions, HIV, and multiple sclerosis.
Expert Reviews Upcoming Approvals, Trends in Biosimilars
Jensen notes that although she expects there will be a lot of FDA approvals in 2023 and 2024, there likely will not be another biosimilar “boom” until 2025.
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Jeff J, Mclntyre, MA, Vice President of Liver Health Programs, Global Liver Institute, discussed the clinical and economic burden of NASH
Medically Integrated Dispensing Pharmacies Access Patient Medical Records To More Effectively Manage Patients
Medically integrated dispensing specialty pharmacies can connect patient medical and pharmacy records to improve medication adherence and help patients to safely stay on them for longer.
Artificial Intelligence Helps Simplify Managed Care Pharmacy Workflow, Processes
Artificial intelligence and machine learning can significantly benefit managed care pharmacy, specifically in contract reading and interpretation.
Current Perceptions Affect Managed Care of Obesity as Chronic Condition
Obesity is a chronic disease comprised of dysregulated adipose tissue, increasing the risk of developing serious health conditions, and requires more than just losing weight.
Access Barriers to Rifaximin May Increase Risk of Hospitalization from Overt Hepatic Encephalopathy
In a recent study, 97% of patients had to wait a day before receiving their prescription, and this may worsen the risk of hospitalization.
AMCP Session Provides Updates on PBM Reform Efforts Currently Stalled in Congress
Reform efforts to consider how health care plans may capitalize on disclosures, balancing out-of-pocket spending access, and how pharmacists can help plan members with the increased transparency of pharmacy benefit managers.
Medically Integrated Specialty Pharmacies Can Leverage Electronic Medical Records to Improve Quality of Care
These pharmacies can use electronic medical records to work more directly with providers, monitoring adverse medication effects and assessment schedules and being more tuned into patient needs.
Value Assessment Tools Help Collect Data, Determine Spending
Kimberly Westrich, MA, discussed value assessment tools and how they can help make key decisions in health care spending.
Updates in Federal Legislation Addressing Digital Therapeutics, Access to Care
Although all legislation is currently on hold in Congress, there are important actions under consideration for pharmacy, including digital therapeutics, access to care, and health care disparities.
Expert: What to Expect From AMCP Nexus 2023
Jennifer Mathieu, MA from the Academy of Managed Care Pharmacy (AMCP) discusses what to expect from AMCP Nexus 2023 and some of the sessions she is looking forward to.
Five Key Sessions at the Academy of Managed Care Pharmacy Nexus 2023 Conference
Pharmacy Times will be providing exclusive session coverage and interviews with presenters for the Academy of Managed Care Pharmacy Nexus 2023 conference.
Clinical Results Support Greater Use of Oncology Biosimilars
Presenters at the AMCP Nexus conference explore outcomes data and whether these medications should be substituted for reference products more frequently.
Pharmacists Can Affirm Transgender, Non-Binary Patients
A presentation at the AMCP Nexus conference focuses on the health care disparities and pharmacotherapy options for gender affirmation.
AMCP Urges Members to Support Pre-Approval Information Exchange Legislation
Presentation at the AMCP Nexus conference focuses on midterm election outlook and a plug for the Pre-approval Information Exchange Act.
Specialty Drugs Account for Nearly Half of Pharmacy Drug Spend in 2021
Keynote speaker at the AMCP Nexus conference discusses recent FDA approvals and those scheduled over the next year.
Pharmacy Professionals Discuss Working in Managed Care
Panelists at the AMCP Nexus conference share tips on new opportunities for students and career-changers looking to forge a new path.
Pharmacists Can Help Identify, Treat Anemia of CKD
Panelists at the AMCP Nexus conference discuss the burden of undertreated and untreated chronic kidney disease.
Differentiating Bipolar I Disorder From Major Depressive Disorder Presents Challenges
Experts discuss the clinical and economic impact of misdiagnosing bipolar I disorder as major depressive disorder.
2 Clarke Drive Cranbury, NJ 08512